Asaf Yanir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Asaf Yanir has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Michael Weintraub
Department of Pediatric Hematology–Oncology and Bone Marrow Transplantation, Hadassah University Hospital, Jerusalem, Israel
2 shared publicationsAmir Zilkha
1 shared publicationDalia Bouhanna
1 shared publicationIdo Yatsiv
1 shared publicationJacques Braun
1 shared publicationMahmud Abed Allatif
Department of Tissue typing, Hadassah University Hospital, Jerusalem, Israel
1 shared publication
Latest Publications
- 30 June 2013
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 109 (2) , 224-226
Unfavorable outcome of hematopoietic stem cell transplantation in two siblings with Wolman disease due to graft failure and hepatic complications
- 30 June 2013
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 109 (2) , 224-226
Unfavorable outcome of hematopoietic stem cell transplantation in two siblings with Wolman disease due to graft failure and hepatic complications
- 1 July 2012
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 34 (5) , e209-e211
Rare Complications After Second Hematopoietic Stem Cell Transplantation for Thalassemia Major
We describe an 11-year-old girl with thalassemia major who underwent a second hematopoietic stem cell transplantation from a matched related donor and who subsequently developed posttransplant lymphoproliferative disorder complicated by severe ascending paralysis resembling Guillian-Barré syndrome. Six months later she developed a massive pericardial effusion. She received a multimodal treatment for these complications and currently, 18 months after transplantation, she is in a good clinical condition, is transfusion independent, with no evidence of graft-versus-host disease and off all treatment. This case highlights the dilemma surrounding second hematopoietic stem cell transplantations in hemoglobinopathies and the need for a careful, well informed, and collaborative decision-making process by patients, families, and medical professionals.
- 1 July 2012
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 34 (5) , e209-e211
Rare Complications After Second Hematopoietic Stem Cell Transplantation for Thalassemia Major
We describe an 11-year-old girl with thalassemia major who underwent a second hematopoietic stem cell transplantation from a matched related donor and who subsequently developed posttransplant lymphoproliferative disorder complicated by severe ascending paralysis resembling Guillian-Barré syndrome. Six months later she developed a massive pericardial effusion. She received a multimodal treatment for these complications and currently, 18 months after transplantation, she is in a good clinical condition, is transfusion independent, with no evidence of graft-versus-host disease and off all treatment. This case highlights the dilemma surrounding second hematopoietic stem cell transplantations in hemoglobinopathies and the need for a careful, well informed, and collaborative decision-making process by patients, families, and medical professionals.